{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:49:29Z","timestamp":1781113769782,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1010104","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000}}],"reference-count":108,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"crossref","award":["APP1165978"],"award-info":[{"award-number":["APP1165978"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP18010512"],"award-info":[{"award-number":["DP18010512"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Centre for Data Science","award":["First Byte Funding"],"award-info":[{"award-number":["First Byte Funding"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    The prognosis for pancreatic ductal adenocarcinoma (PDAC) patients has not significantly improved in the past 3 decades, highlighting the need for more effective treatment approaches. Poor patient outcomes and lack of response to therapy can be attributed, in part, to a lack of uptake of perfusion of systemically administered chemotherapeutic drugs into the tumour. Wet-spun alginate fibres loaded with the chemotherapeutic agent gemcitabine have been developed as a potential tool for overcoming the barriers in delivery of systemically administrated drugs to the PDAC tumour microenvironment by delivering high concentrations of drug to the tumour directly over an extended period. While exciting, the practicality, safety, and effectiveness of these devices in a clinical setting requires further investigation. Furthermore, an in-depth assessment of the drug-release rate from these devices needs to be undertaken to determine whether an optimal release profile exists. Using a hybrid computational model (agent-based model and partial differential equation system), we developed a simulation of pancreatic tumour growth and response to treatment with gemcitabine loaded alginate fibres. The model was calibrated using\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    data and simulated using a finite volume method discretisation. We then used the model to compare different intratumoural implantation protocols and gemcitabine-release rates. In our model, the primary driver of pancreatic tumour growth was the rate of tumour cell division. We were able to demonstrate that intratumoural placement of gemcitabine loaded fibres was more effective than peritumoural placement. Additionally, we quantified the efficacy of different release profiles from the implanted fibres that have not yet been tested experimentally. Altogether, the model developed here is a tool that can be used to investigate other drug delivery devices to improve the arsenal of treatments available for PDAC and other difficult-to-treat cancers in the future.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1010104","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T23:06:18Z","timestamp":1673996778000},"page":"e1010104","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Examining the efficacy of localised gemcitabine therapy for the treatment of pancreatic cancer using a hybrid agent-based model"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9103-7092","authenticated-orcid":true,"given":"Adrianne L.","family":"Jenner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8554-4589","authenticated-orcid":true,"given":"Wayne","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dallaston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-2214","authenticated-orcid":true,"given":"Robyn","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-9844","authenticated-orcid":true,"given":"Isobelle","family":"Parfitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-2412","authenticated-orcid":true,"given":"Dominic","family":"Steinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8205-0914","authenticated-orcid":true,"given":"Pantea","family":"Pooladvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-4744","authenticated-orcid":true,"given":"Peter S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-8518","authenticated-orcid":true,"given":"Samantha J.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6871-1149","authenticated-orcid":true,"given":"Kara L.","family":"Vine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"pcbi.1010104.ref001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000055290","article-title":"Gemcitabine: progress in the treatment of pancreatic cancer","volume":"60","author":"V Heinemann","year":"2001","journal-title":"Oncology"},{"key":"pcbi.1010104.ref002","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first\u2013line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"3rd HA Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"pcbi.1010104.ref003","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1080\/00365520902745039","article-title":"Gemcitabine chemoresistance in pancreatic cancer: molecular mechanisms and potential solutions","volume":"44","author":"R Andersson","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"pcbi.1010104.ref004","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-04-1785","article-title":"Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer","volume":"11","author":"M Akada","year":"2005","journal-title":"Clin Cancer Res"},{"key":"pcbi.1010104.ref005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer","volume":"741","author":"L de Sousa Cavalcante","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"pcbi.1010104.ref006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ijc.1351","article-title":"Cell cycle effects of gemcitabine","volume":"93","author":"P Cappella","year":"2001","journal-title":"Int J cancer"},{"key":"pcbi.1010104.ref007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1756283X15622601","article-title":"Recent advances in pancreatic cancer: Updates and insights from the 2015 annual meeting of the American Society of Clinical Oncology","volume":"9","author":"MJ Abrams","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"pcbi.1010104.ref008","author":"L Toschi","year":"2005","journal-title":"Role of gemcitabine in cancer therapy"},{"key":"pcbi.1010104.ref009","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab\u2013paclitaxel plus gemcitabine","volume":"369","author":"DD Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"pcbi.1010104.ref010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijbiomac.2019.09.013","article-title":"Drug release and kinetic models of anticancer drug (BTZ) from a pH\u2013responsive alginate polydopamine hydrogel: Towards cancer chemotherapy","volume":"141","author":"AI Rezk","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"pcbi.1010104.ref011","doi-asserted-by":"crossref","first-page":"103120","DOI":"10.1016\/j.arabjc.2021.103120","article-title":"Nanocomposite hydrogels for melanoma skin cancer care and treatment: In\u2013vitro drug delivery, drug release kinetics and anti\u2013cancer activities","volume":"14","author":"S Nazir","year":"2021","journal-title":"Arab J Chem"},{"key":"pcbi.1010104.ref012","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/nmat3758","article-title":"Macroscale delivery systems for molecular and cellular payloads","volume":"12","author":"CJ Kearney","year":"2013","journal-title":"Nat Mater"},{"key":"pcbi.1010104.ref013","article-title":"Dual Delivery of Gemcitabine and Paclitaxel by Wet\u2013Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitizes Cells to Radiation","author":"SJ Wade","year":"2020","journal-title":"Adv Healthc Mater 9:2001115"},{"key":"pcbi.1010104.ref014","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.pan.2017.06.001","article-title":"Preparation and in vitro assessment of wet\u2013spun gemcitabine\u2013loaded polymeric fibers: Towards localized drug delivery for the treatment of pancreatic cancer","volume":"17","author":"SJ Wade","year":"2017","journal-title":"Pancreatology"},{"key":"pcbi.1010104.ref015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.progpolymsci.2011.06.003","article-title":"Alginate: Properties and biomedical applications","volume":"37","author":"KY Lee","year":"2012","journal-title":"Prog Polym Sci"},{"key":"pcbi.1010104.ref016","author":"SJ Wade","year":"2019","journal-title":"Fabrication and preclinical assessment of drug eluting wet spun fibres for pancreatic cancer treatment"},{"key":"pcbi.1010104.ref017","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jtbi.2014.02.028","article-title":"A mathematical model for pancreatic cancer growth and treatments","volume":"351","author":"Y Louzoun","year":"2014","journal-title":"J Theor Biol"},{"key":"pcbi.1010104.ref018","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mbs.2019.06.001","article-title":"Numerical optimal control of a size\u2013structured PDE model for metastatic cancer treatment","volume":"314","author":"J Liu","year":"2019","journal-title":"Math Biosci"},{"key":"pcbi.1010104.ref019","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jtbi.2018.11.018","article-title":"Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs","volume":"462","author":"X Lai","year":"2019","journal-title":"J Theor Biol"},{"key":"pcbi.1010104.ref020","doi-asserted-by":"crossref","first-page":"108456","DOI":"10.1016\/j.mbs.2020.108456","article-title":"A computational study of combination HIFU\u2013chemotherapy as a potential means of overcoming cancer drug resistance","volume":"329","author":"M Ghasemi","year":"2020","journal-title":"Math Biosci"},{"key":"pcbi.1010104.ref021","doi-asserted-by":"crossref","first-page":"41005","DOI":"10.1088\/1478-3975\/ab1a09","article-title":"The 2019 mathematical oncology roadmap","volume":"16","author":"RC Rockne","year":"2019","journal-title":"Phys Biol"},{"key":"pcbi.1010104.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10544-019-0380-2","article-title":"Mathematical modeling in cancer nanomedicine: a review","volume":"21","author":"P Dogra","year":"2019","journal-title":"Biomed Microdevices"},{"key":"pcbi.1010104.ref023","first-page":"2127","article-title":"Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies","volume":"78","author":"JA Gallaher","year":"2017","journal-title":"bioRxiv"},{"key":"pcbi.1010104.ref024","doi-asserted-by":"crossref","first-page":"e1007672","DOI":"10.1371\/journal.pcbi.1007672","article-title":"From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response","volume":"16","author":"JA Gallaher","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1010104.ref025","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1002\/cso2.1018","article-title":"Biomechanical modelling of cancer: Agent\u2013based force\u2013based models of solid tumours within the context of the tumour microenvironment","volume":"1","author":"CK Macnamara","year":"2021","journal-title":"Comput Syst Oncol"},{"key":"pcbi.1010104.ref026","doi-asserted-by":"crossref","first-page":"101067","DOI":"10.1016\/j.jocs.2019.101067","article-title":"Computational modelling and simulation of cancer growth and migration within a 3D heterogeneous tissue: The effects of fibre and vascular structure","volume":"40","author":"CK Macnamara","year":"2020","journal-title":"J Comput Sci"},{"key":"pcbi.1010104.ref027","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s11538-017-0292-3","article-title":"Computational Modelling of Cancer Development and Growth: Modelling at Multiple Scales and Multiscale Modelling","volume":"80","author":"Z Szyma\u0144ska","year":"2018","journal-title":"Bull Math Biol"},{"key":"pcbi.1010104.ref028","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymeth.2020.01.006","article-title":"An in silico hybrid continuum\u2013\/agent\u2013based procedure to modelling cancer development: Interrogating the interplay amongst glioma invasion, vascularity and necrosis","volume":"185","author":"J de Montigny","year":"2021","journal-title":"Methods"},{"key":"pcbi.1010104.ref029","doi-asserted-by":"crossref","first-page":"e1008519","DOI":"10.1371\/journal.pcbi.1008519","article-title":"Multi\u2013scale modeling of macrophage\u2014T cell interactions within the tumor microenvironment","volume":"16","author":"CG Cess","year":"2020","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1010104.ref030","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.1002\/cso2.1032","article-title":"Multiscale modeling of tumor adaption and invasion following anti\u2013angiogenic therapy","volume":"2","author":"CG Cess","year":"2022","journal-title":"Comput Syst Oncol"},{"key":"pcbi.1010104.ref031","doi-asserted-by":"crossref","first-page":"e0231137","DOI":"10.1371\/journal.pone.0231137","article-title":"A hybrid model of tumor growth and angiogenesis: In silico experiments","volume":"15","author":"CM Phillips","year":"2020","journal-title":"PLoS One"},{"key":"pcbi.1010104.ref032","doi-asserted-by":"crossref","first-page":"20210903","DOI":"10.1098\/rsif.2021.0903","article-title":"A stochastic mathematical model of 4D tumour spheroids with real\u2013time fluorescent cell cycle labelling","volume":"19","author":"JJ Klowss","year":"2022","journal-title":"J R Soc Interface"},{"key":"pcbi.1010104.ref033","doi-asserted-by":"crossref","first-page":"e1002547","DOI":"10.1371\/journal.pcbi.1002547","article-title":"Complex spatial dynamics of oncolytic viruses in vitro: mathematical and experimental approaches","volume":"8","author":"D Wodarz","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1010104.ref034","doi-asserted-by":"crossref","first-page":"20170320","DOI":"10.1098\/rsif.2017.0320","article-title":"A computational multiscale agent\u2013based model for simulating spatio\u2013temporal tumour immune response to PD1 and PDL1 inhibition","volume":"14","author":"C Gong","year":"2017","journal-title":"J R Soc Interface"},{"key":"pcbi.1010104.ref035","author":"M Benmir","year":"2022","journal-title":"A Hybrid Model of Tumor Growth Under Chemotherapy Medicine To cite this version: HAL Id: hal\u201303715363 A Hybrid Model of Tumor Growth Under Chemotherapy Medicine"},{"key":"pcbi.1010104.ref036","article-title":"Optimization of Dose Schedules for Chemotherapy of Early Colon Cancer Determined by High\u2013Performance Computer Simulations","author":"C Cockrell","year":"2019","journal-title":"Cancer Inform"},{"key":"pcbi.1010104.ref037","article-title":"Discrete and continuum phenotype\u2013structured models for the evolution of cancer cell populations under chemotherapy","author":"REA Stace","year":"2020","journal-title":"Math Model Nat Phenom"},{"key":"pcbi.1010104.ref038","first-page":"1","article-title":"Computational modeling of 3D tumor growth and angiogenesis for chemotherapy evaluation","volume":"9","author":"L Tang","year":"2014","journal-title":"PLoS One"},{"key":"pcbi.1010104.ref039","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10928-015-9403-7","article-title":"Integrated PK\u2013PD and agent\u2013based modeling in oncology","volume":"42","author":"Z Wang","year":"2015","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"pcbi.1010104.ref040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13873954.2019.1571515","article-title":"A cellular automata model of chemotherapy effects on tumour growth: targeting cancer and immune cells","volume":"25","author":"F Pourhasanzade","year":"2019","journal-title":"Math Comput Model Dyn Syst"},{"key":"pcbi.1010104.ref041","doi-asserted-by":"crossref","first-page":"107585","DOI":"10.1016\/j.compbiolchem.2021.107585","article-title":"Modeling codelivery of CD73 inhibitor and dendritic cell\u2013based vaccines in cancer immunotherapy","volume":"95","author":"A Arabameri","year":"2021","journal-title":"Comput Biol Chem"},{"key":"pcbi.1010104.ref042","article-title":"High\u2013throughput cancer hypothesis testing with an integrated PhysiCell\u2013EMEWS workflow","author":"J Ozik","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"pcbi.1010104.ref043","doi-asserted-by":"crossref","first-page":"e1005991","DOI":"10.1371\/journal.pcbi.1005991","article-title":"PhysiCell: An open source physics\u2013based cell simulator for 3\u2013D multicellular systems","volume":"14","author":"A Ghaffarizadeh","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1010104.ref044","doi-asserted-by":"crossref","first-page":"102935","DOI":"10.1016\/j.isci.2021.102935","article-title":"A persistent invasive phenotype in post\u2013hypoxic tumor cells is revealed by fate mapping and computational modeling","volume":"24","author":"HL Rocha","year":"2021","journal-title":"iScience"},{"key":"pcbi.1010104.ref045","article-title":"Stromal density shapes the response to HSV\u20131 oncolytic virus rQNestin in brain tumours","author":"A Jenner","year":"2021","journal-title":"Submitted"},{"key":"pcbi.1010104.ref046","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-030-55874-1_25","volume-title":"Numer. Math. Adv. Appl. ENUMATH 2019","author":"J Chen","year":"2021"},{"key":"pcbi.1010104.ref047","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1568026620666200101095641","article-title":"Mathematical modeling to address challenges in pancreatic cancer","volume":"20","author":"P Dogra","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"pcbi.1010104.ref048","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.addr.2006.09.007","article-title":"Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems","volume":"58","author":"DY Arifin","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"pcbi.1010104.ref049","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijpharm.2010.12.020","article-title":"Modeling of drug release from bulk\u2013degrading polymers","volume":"418","author":"LL Lao","year":"2011","journal-title":"Int J Pharm"},{"key":"pcbi.1010104.ref050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jconrel.2011.10.006","article-title":"Modeling of diffusion controlled drug delivery","volume":"161","author":"J Siepmann","year":"2012","journal-title":"J Control Release"},{"key":"pcbi.1010104.ref051","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1021\/mp500078u","article-title":"Mathematical modeling of PLGA microparticles: From polymer degradation to drug release","volume":"11","author":"T Casalini","year":"2014","journal-title":"Mol Pharm"},{"key":"pcbi.1010104.ref052","first-page":"51","article-title":"Mathematical modelling of variable porosity coatings for controlled drug release","volume":"45","author":"S McGinty","year":"2017","journal-title":"arXiv"},{"key":"pcbi.1010104.ref053","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.3390\/app10082872","article-title":"Optimising hydrogel release profiles for viro\u2013immunotherapy using oncolytic adenovirus expressing IL\u201312 and GM\u2013CSF with immature dendritic cells","volume":"10","author":"AL Jenner","year":"2020","journal-title":"Appl Sci"},{"key":"pcbi.1010104.ref054","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejps.2017.09.038","article-title":"A new mathematical approach to predict the actual drug release from hydrogels","volume":"111","author":"AHZ Kalkhoran","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"pcbi.1010104.ref055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.xphs.2016.10.019","article-title":"Mathematical models for controlled drug release through pH\u2013responsive polymeric hydrogels","volume":"106","author":"RD Manga","year":"2017","journal-title":"J Pharm Sci"},{"key":"pcbi.1010104.ref056","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.xphs.2019.03.036","article-title":"Investigation of the Size Distribution for Diffusion\u2013Controlled Drug Release From Drug Delivery Systems of Various Geometries","volume":"108","author":"TI Spiridonova","year":"2019","journal-title":"J Pharm Sci"},{"key":"pcbi.1010104.ref057","article-title":"Enhancing oncolytic virotherapy: Observations from a Voronoi Cell\u2013Based model","author":"AL Jenner","year":"2020","journal-title":"J Theor Biol"},{"key":"pcbi.1010104.ref058","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/bioinformatics\/btv730","article-title":"BioFVM: An efficient, parallelized diffusive transport solver for 3\u2013D biological simulations","volume":"32","author":"A Ghaffarizadeh","year":"2016","journal-title":"Bioinformatics"},{"key":"pcbi.1010104.ref059","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1002\/jps.24669","article-title":"Pathway Distribution Model for Solute Transport in Stratum Corneum","volume":"104","author":"DG Petlin","year":"2015","journal-title":"J Pharm Sci"},{"key":"pcbi.1010104.ref060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jconrel.2017.05.021","article-title":"A fi ber distribution model for predicting drug release rates","volume":"258","author":"DG Petlin","year":"2017","journal-title":"J Control Release"},{"key":"pcbi.1010104.ref061","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijpharm.2011.01.021","article-title":"Mechanistic modelling of drug release from polymer\u2013coated and swelling and dissolving polymer matrix systems","volume":"418","author":"E Kaunisto","year":"2011","journal-title":"Int J Pharm"},{"key":"pcbi.1010104.ref062","first-page":"1","article-title":"A second order control\u2013volume finite\u2013element least\u2013squares strategy for simulating diffusion in strongly anisotropic media","author":"J Pasdunkorale A","year":"2005","journal-title":"J Comput Math"},{"key":"pcbi.1010104.ref063","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.camwa.2018.09.006","article-title":"In silico modeling for the risk assessment of toxicity in cells","volume":"77","author":"QA Chaudhry","year":"2019","journal-title":"Comput \\& Math with Appl"},{"key":"pcbi.1010104.ref064","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1016\/j.camwa.2011.09.049","article-title":"The finite volume spectral element method to solve Turing models in the biological pattern formation. Comput \\&","volume":"62","author":"F Shakeri","year":"2011","journal-title":"Math with Appl"},{"key":"pcbi.1010104.ref065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00285-010-0369-1","article-title":"Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation","volume":"63","author":"V Andasari","year":"2011","journal-title":"J Math Biol"},{"key":"pcbi.1010104.ref066","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jtbi.2012.09.031","article-title":"Multiphase modelling of vascular tumour growth in two spatial dimensions","volume":"316","author":"ME Hubbard","year":"2013","journal-title":"J Theor Biol"},{"key":"pcbi.1010104.ref067","first-page":"713","article-title":"Finite volume methods","volume":"7","author":"R Eymard","year":"2000","journal-title":"Handb Numer Anal"},{"key":"pcbi.1010104.ref068","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.camwa.2019.03.047","article-title":"Quantitative analysis of cancer risk assessment in a mammalian cell with the inclusion of mitochondria. Comput \\&","volume":"78","author":"S Khalid","year":"2019","journal-title":"Math with Appl"},{"key":"pcbi.1010104.ref069","first-page":"12001","article-title":"Modeling of electrical impedance tomography to detect breast cancer by finite volume methods","author":"K Ain","year":"2017","journal-title":"In: J. Phys. Conf. Ser"},{"key":"pcbi.1010104.ref070","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.3390\/cancers13215314","article-title":"An Agent\u2013Based Model of Combination Oncolytic Viral Therapy and Anti\u2013PD\u20131 Immunotherapy Reveals the Importance of Spatial Location When Treating Glioblastoma","volume":"13","author":"KM Storey","year":"2021","journal-title":"Cancers (Basel)"},{"key":"pcbi.1010104.ref071","first-page":"191","article-title":"Cellular sociology of proliferating tumor cells in invasive ductal breast cancer","volume":"18","author":"G Haroske","year":"1996","journal-title":"Anal Quant Cytol Histol"},{"key":"pcbi.1010104.ref072","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11538-009-9498-3","article-title":"Generalized voronoi tessellation as a model of two\u2013dimensional cell tissue dynamics","volume":"72","author":"M Bock","year":"2010","journal-title":"Bull Math Biol"},{"key":"pcbi.1010104.ref073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/JTEHM.2016.2578331","article-title":"Spatial Heterogeneity Analysis in Evaluation of Cell Viability and Apoptosis for Colorectal Cancer Cells","volume":"4","author":"A Saribudak","year":"2016","journal-title":"IEEE J Transl Eng Heal Med"},{"key":"pcbi.1010104.ref074","first-page":"203","article-title":"Geometrical modeling of cell division and cell remodeling based on Voronoi tessellation method","volume":"98","author":"L Lin","year":"2014","journal-title":"C Comput Model Eng \\& Sci"},{"key":"pcbi.1010104.ref075","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1109\/EMBC.2015.7319383","article-title":"Mathematical models of tumor growth using Voronoi tessellations in pathology slides of kidney cancer","author":"A Saribudak","year":"2015","journal-title":"2015 37th Annu. Int. Conf. IEEE Eng. Med. Biol. Soc."},{"key":"pcbi.1010104.ref076","article-title":"Epithelial\u2013mesenchymal transition in pancreatic carcinoma","author":"HJ Maier","year":"2010","journal-title":"Cancers (Basel) 2:2058\u20132083"},{"key":"pcbi.1010104.ref077","first-page":"1228","article-title":"Epithelial\u2013mesenchymal transition and its regulation mechanisms in pancreatic cancer","volume":"11","author":"T Luu","year":"2021","journal-title":"Front Oncol"},{"key":"pcbi.1010104.ref078","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fonc.2013.00221","article-title":"Role of epithelial\u2013mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link","volume":"3","author":"E Karamitopoulou","year":"2013","journal-title":"Front Oncol"},{"key":"pcbi.1010104.ref079","first-page":"1","article-title":"Beyond just a tight fortress: contribution of stroma to epithelial\u2013mesenchymal transition in pancreatic cancer","volume":"5","author":"A Bulle","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"pcbi.1010104.ref080","doi-asserted-by":"crossref","first-page":"H2651","DOI":"10.1152\/ajpheart.00332.2004","article-title":"Mathematical modeling of vascular endothelial layer maintenance: the role of endothelial cell division, progenitor cell homing, and telomere shortening","volume":"287","author":"JO den Buijs","year":"2004","journal-title":"Am J Physiol Circ Physiol"},{"key":"pcbi.1010104.ref081","volume-title":"Modelling the Role of Interclonal Cooperativity During Early Carcinogenesis","author":"EP Lobo","year":"2014"},{"key":"pcbi.1010104.ref082","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/jtbi.2000.2000","article-title":"Simulated brain tumor growth dynamics using a three\u2013dimensional cellular automaton","volume":"203","author":"AR Kansal","year":"2000","journal-title":"J Theor Biol"},{"key":"pcbi.1010104.ref083","doi-asserted-by":"crossref","first-page":"e1002314","DOI":"10.1371\/journal.pcbi.1002314","article-title":"Emergent behaviors from a cellular automaton model for invasive tumor growth in heterogeneous microenvironments","volume":"7","author":"Y Jiao","year":"2011","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1010104.ref084","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1073\/pnas.1323016111","article-title":"Spatial constraints control cell proliferation in tissues","volume":"111","author":"SJ Streichan","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"pcbi.1010104.ref085","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.bpj.2014.08.031","article-title":"Compressive stress inhibits proliferation in tumor spheroids through a volume limitation","volume":"107","author":"M Delarue","year":"2014","journal-title":"Biophys J"},{"key":"pcbi.1010104.ref086","first-page":"69","article-title":"Solid stress, competition for space and cancer: The opposing roles of mechanical cell competition in tumour initiation and growth","author":"R Levayer","year":"2020","journal-title":"In: Semin. Cancer Biol"},{"key":"pcbi.1010104.ref087","article-title":"Procaspase\u2013Activating Compound\u20131 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.","author":"P Crosley","year":"2021","journal-title":"Int J Mol Sci 22:4699"},{"key":"pcbi.1010104.ref088","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11095-006-9135-x","article-title":"Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition","volume":"24","author":"JC Kalvass","year":"2007","journal-title":"Pharm Res"},{"key":"pcbi.1010104.ref089","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1371\/journal.pbio.1001540","article-title":"When the Most Potent Combination of Antibiotics Selects for the Greatest Bacterial Load: The Smile\u2013Frown Transition","volume":"11","author":"R Pena\u2013Miller","year":"2013","journal-title":"PLoS Biol"},{"key":"pcbi.1010104.ref090","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00000542-200006000-00017","article-title":"Response surface model for anesthetic drug interactions","volume":"92","author":"CF Minto","year":"2000","journal-title":"Anesthesiology"},{"key":"pcbi.1010104.ref091","article-title":"Six1 Promotes Proliferation of Pancreatic Cancer Cells via Upregulation of Cyclin D1 Expression.","author":"Z Li","year":"2013","journal-title":"PLoS One"},{"key":"pcbi.1010104.ref092","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.molonc.2014.04.007","article-title":"Mesenchymal\u2013like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial\u2013like counterparts","volume":"8","author":"A Sinha","year":"2014","journal-title":"Mol Oncol"},{"key":"pcbi.1010104.ref093","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0624-9","article-title":"The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cance","volume":"16","author":"P Zhou","year":"2017","journal-title":"Mol Cancer"},{"key":"pcbi.1010104.ref094","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fonc.2019.00688","article-title":"Targeting the interplay between cancer fibroblasts, mesenchymal stem cells, and cancer stem cells in desmoplastic cancers","volume":"9","author":"S Chan T\u2013","year":"2019","journal-title":"Front Oncol"},{"key":"pcbi.1010104.ref095","article-title":"Spatial and Functional Heterogeneities Shape Collective Behavior of Tumor\u2013Immune Networks","author":"DK Wells","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1010104.ref096","article-title":"Epithelial\u2013mesenchymal transition in pancreatic cancer: a review","author":"S Wang","year":"2017","journal-title":"Biomed Res. Int"},{"key":"pcbi.1010104.ref097","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2013.71","article-title":"Basic concepts in population modeling, simulation, and model\u2013based drug development: Part 3\u2013introduction to pharmacodynamic modeling methods.","volume":"3","author":"RN Upton","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"pcbi.1010104.ref098","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1124\/pr.118.015750","article-title":"Dose\u2013response\u2013time data analysis: an underexploited trinity","volume":"71","author":"J Gabrielsson","year":"2019","journal-title":"Pharmacol Rev"},{"key":"pcbi.1010104.ref099","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12154-009-0029-3","article-title":"Hill coefficients, dose\u2013\u2013response curves and allosteric mechanisms","volume":"3","author":"H Prinz","year":"2010","journal-title":"J Chem Biol"},{"key":"pcbi.1010104.ref100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11605-012-2064-6","article-title":"Addition of algenpantucel\u2013L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study","volume":"17","author":"JM Hardacre","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"pcbi.1010104.ref101","first-page":"4114","article-title":"The PDAC Extracellular Matrix: A Review of the ECM Protein Composition, Tumor Cell Interaction, and Therapeutic Strategies","author":"VM Perez","year":"2021","journal-title":"Front Oncol"},{"key":"pcbi.1010104.ref102","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.gendis.2015.01.002","article-title":"Pancreatic cancer stromal biology and therapy","volume":"2","author":"D Xie","year":"2015","journal-title":"Genes \\& Dis"},{"key":"pcbi.1010104.ref103","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/17513758.2011.613486","article-title":"A mathematical model for cell cycle\u2013specific cancer virotherapy","volume":"6","author":"JJ Crivelli","year":"2012","journal-title":"J Biol Dyn"},{"key":"pcbi.1010104.ref104","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0024-3205(95)02359-3","article-title":"Modulation of the length of the cell cycle time of MCF\u20137 human breast cancer cells by melatonin","volume":"58","author":"S Cos","year":"1996","journal-title":"Life Sci"},{"key":"pcbi.1010104.ref105","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"T Conroy","year":"2018","journal-title":"N Engl J Med"},{"key":"pcbi.1010104.ref106","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"MJ Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"pcbi.1010104.ref107","article-title":"Engineering in Medicine to Address the Challenge of Cancer Drug Resistance: From Micro: From Nanotechnologies to Computational and Mathematical Modeling","author":"M Craig","year":"2020","journal-title":"Chem Rev"},{"key":"pcbi.1010104.ref108","doi-asserted-by":"crossref","first-page":"e1009348","DOI":"10.1371\/journal.pcbi.1009348","article-title":"The role of memory in non\u2013genetic inheritance and its impact on cancer treatment resistance","volume":"17","author":"T Cassidy","year":"2021","journal-title":"PLoS Comput Biol"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1010104","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T17:05:54Z","timestamp":1701709554000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010104"}},"subtitle":[],"editor":[{"given":"Philip K.","family":"Maini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1010104","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.04.18.488716","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}